- Home
- ARCT vs EMO Comparison
ARCT vs EMO Comparison
Compare ARCT & EMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- EMO
- Stock Information
- Founded
- ARCT 2013
- EMO 2011
- Country
- ARCT United States
- EMO United States
- Employees
- ARCT N/A
- EMO N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- EMO Investment Managers
- Sector
- ARCT Health Care
- EMO Finance
- Exchange
- ARCT Nasdaq
- EMO Nasdaq
- Market Cap
- ARCT 487.0M
- EMO 599.1M
- IPO Year
- ARCT N/A
- EMO N/A
- Fundamental
- Price
- ARCT $16.43
- EMO $51.05
- Analyst Decision
- ARCT Strong Buy
- EMO
- Analyst Count
- ARCT 7
- EMO 0
- Target Price
- ARCT $65.00
- EMO N/A
- AVG Volume (30 Days)
- ARCT 388.1K
- EMO 27.1K
- Earning Date
- ARCT 03-06-2025
- EMO 01-01-0001
- Dividend Yield
- ARCT N/A
- EMO 6.70%
- EPS Growth
- ARCT N/A
- EMO N/A
- EPS
- ARCT N/A
- EMO N/A
- Revenue
- ARCT $160,399,000.00
- EMO N/A
- Revenue This Year
- ARCT $7.33
- EMO N/A
- Revenue Next Year
- ARCT $4.71
- EMO N/A
- P/E Ratio
- ARCT N/A
- EMO N/A
- Revenue Growth
- ARCT N/A
- EMO N/A
- 52 Week Low
- ARCT $14.30
- EMO $26.42
- 52 Week High
- ARCT $45.00
- EMO $40.17
- Technical
- Relative Strength Index (RSI)
- ARCT 46.39
- EMO 74.60
- Support Level
- ARCT $15.92
- EMO $49.02
- Resistance Level
- ARCT $17.93
- EMO $51.87
- Average True Range (ATR)
- ARCT 1.41
- EMO 0.94
- MACD
- ARCT -0.10
- EMO 0.50
- Stochastic Oscillator
- ARCT 15.54
- EMO 86.44
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.
About EMO ClearBridge Energy Midstream Opportunity Fund Inc.
ClearBridge Energy Midstream Opportunity Fund Inc is a non-diversified, closed-end management investment company. Its investment objective is to provide long-term investors with a high level of total return with an emphasis on cash distributions.